HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Juhan-Vague Selected Research

Lipids

10/2005Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Juhan-Vague Research Topics

Disease

14Insulin Resistance
06/2007 - 08/2000
11Coronary Disease (Coronary Heart Disease)
01/2010 - 12/2000
10Obesity
05/2005 - 04/2000
7Thrombosis (Thrombus)
05/2010 - 11/2000
7Myocardial Infarction
01/2010 - 04/2000
6Venous Thrombosis (Deep-Vein Thrombosis)
05/2010 - 04/2000
6Inflammation (Inflammations)
12/2007 - 07/2003
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2009 - 02/2000
4Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2007 - 06/2004
3Unstable Angina
01/2010 - 06/2001
3Atherosclerosis
12/2004 - 06/2001
2Hypertension (High Blood Pressure)
01/2010 - 01/2000
2Angina Pectoris
03/2004 - 02/2000
2Weight Gain
02/2002 - 04/2000
2Abdominal Obesity
03/2001 - 04/2000
1Endotoxemia
12/2007
1Sepsis (Septicemia)
12/2007
1Fibrosis (Cirrhosis)
06/2007
1Gram-Negative Bacterial Infections
06/2007
1Stable Angina
03/2007
1Non-ST Elevated Myocardial Infarction
03/2007
1Acute Coronary Syndrome
03/2007
1ST Elevation Myocardial Infarction
03/2007
1Cardiovascular Diseases (Cardiovascular Disease)
10/2005
1Stroke (Strokes)
10/2005
1Body Weight (Weight, Body)
06/2005
1Pulmonary Embolism
05/2003
1Weight Loss (Weight Reduction)
11/2001
1Hypertrophy
06/2001
1Communicable Diseases (Infectious Diseases)
05/2001
1Thrombophilia
05/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2001
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
05/2001
1Hypertriglyceridemia
03/2001
1von Willebrand Diseases (von Willebrand's Disease)
02/2001
1Necrosis
12/2000
1Ulcerative Colitis
08/2000
1Morbid Obesity
08/2000

Drug/Important Bio-Agent (IBA)

16Plasminogen Activator Inhibitor 1IBA
01/2010 - 04/2000
8Plasminogen Activators (Plasminogen Activator)IBA
12/2007 - 04/2000
7Triglycerides (Triacylglycerol)IBA
01/2010 - 01/2000
6Insulin (Novolin)FDA Link
06/2005 - 11/2000
4Fibrinogen (Factor I)FDA Link
04/2009 - 04/2003
4Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
01/2009 - 05/2002
4Plasminogen InactivatorsIBA
10/2007 - 02/2000
4factor V LeidenIBA
12/2001 - 04/2000
3ThrombinFDA Link
05/2010 - 08/2000
3Prothrombin (Factor II)IBA
05/2010 - 05/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008 - 02/2000
3LipopolysaccharidesIBA
12/2007 - 04/2005
3lipoprotein-associated coagulation inhibitor (TFPI)IBA
03/2007 - 06/2001
3Hemostatics (Antihemorrhagics)IBA
05/2005 - 05/2001
2CholesterolIBA
01/2010 - 02/2000
2FibrinIBA
12/2007 - 12/2000
2Interleukin-6 (Interleukin 6)IBA
04/2005 - 07/2004
2C-Reactive ProteinIBA
07/2004 - 11/2003
2ProinsulinIBA
07/2004 - 11/2003
2Biological ProductsIBA
11/2003 - 03/2001
2AntigensIBA
04/2003 - 05/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
02/2002 - 03/2001
2von Willebrand FactorIBA
03/2001 - 02/2001
1Complement Factor D (Factor D)IBA
01/2010
1AdipokinesIBA
01/2010
1ResistinIBA
01/2010
1AdiponectinIBA
01/2010
1LeptinIBA
01/2010
1HDL CholesterolIBA
01/2010
1CytokinesIBA
10/2008
1Toll-Like Receptor 4IBA
06/2007
1Thromboplastin (Tissue Factor)IBA
03/2007
1Endothelial Protein C ReceptorIBA
12/2005
1LipidsIBA
10/2005
1EnzymesIBA
07/2005
1ImmunosorbentsIBA
07/2005
1Glucose (Dextrose)FDA LinkGeneric
06/2005
1Lipopolysaccharide ReceptorsIBA
12/2004
1plasma protein Z (protein Z)IBA
11/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2002
1Messenger RNA (mRNA)IBA
11/2001
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2001
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2001
1AnticoagulantsIBA
06/2001
1Matrix Metalloproteinases (MMPs)IBA
06/2001
1GelatinasesIBA
06/2001
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2001
1phosphatidylethanolamineIBA
05/2001
1Antiphospholipid AntibodiesIBA
05/2001
1AntibodiesIBA
05/2001
1Apolipoproteins B (ApoB)IBA
03/2001
1BiguanidesIBA
03/2001
1Apolipoproteins E (ApoE)IBA
03/2001
1ApolipoproteinsIBA
03/2001
1Lipoproteins (Lipoprotein)IBA
03/2001
1Apolipoprotein C-IIIIBA
03/2001
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2000
1Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2000
1ABO Blood-Group SystemIBA
04/2000
1Protein Kinases (Protein Kinase)IBA
02/2000
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2000